Company · CIK 1348649
CoLucid Pharmaceuticals, Inc.
| CIK | 1348649 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2015-06-18 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-211865 | 2016-06-06 | 2017-03-03 | 5 | |
| 333-203100 | 2015-03-30 | 2015-05-06 | 9 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2017-03-03 | EFFECTDeclared effective | 333-211865 | 9999999995-17-000484 |
| 2016-09-09 | 424B5Shelf takedown | 333-211865 | 0001193125-16-706447 |
| 2016-09-08 | 424B5Shelf takedown | 333-211865 | 0001193125-16-705152 |
| 2016-06-24 | EFFECTDeclared effective | 333-211865 | 9999999995-16-004999 |
| 2016-06-06 | S-3Shelf registered | 333-211865 | 0001193125-16-613987 |
| 2015-05-06 | 424B4Final prospectus | 333-203100 | 0001193125-15-174241 |
| 2015-05-05 | EFFECTDeclared effective | 333-203100 | 9999999995-15-001225 |
| 2015-05-05 | S-1/AAmendment | 333-203100 | 0001193125-15-171195 |
| 2015-04-30 | S-1/AAmendment | 333-203100 | 0001193125-15-159603 |
| 2015-04-28 | S-1/AAmendment | 333-203100 | 0001193125-15-150251 |
| 2015-04-23 | S-1/AAmendment | 333-203100 | 0001193125-15-143958 |
| 2015-04-20 | S-1/AAmendment | 333-203100 | 0001193125-15-136846 |
| 2015-04-10 | S-1/AAmendment | 333-203100 | 0001193125-15-126262 |
| 2015-03-30 | S-1Registration filed | 333-203100 | 0001193125-15-111971 |
| 2015-02-24 | DRSDraft made public | 377-00938 | 0000950123-15-003602 |